BioSpace News Archive

Biotech Beach

Palisade Bio Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

Palisade Bio announced that J.D. Finley, Chief Executive Officer of Palisade Bio will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest on Thursday, June 22, 2023 at 11:30 AM ET.

June 14, 2023
·
2 min read
Medigene to Present Data Highlighting the Enhanced Tumor Cell Killing Effects of Adding the PD1-41BB Switch Receptor to Multiple TCR-T Therapies at the Immuno-Oncology Summit Europe

Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will be presenting at the 7th annual Immuno-Oncology Summit Europe which will take place June 20-22, 2023 in London, UK.

June 14, 2023
·
4 min read
Biotech Bay

Complete Genomics Announces Updated Mission and New Partnerships on 18th Anniversary

Complete Genomics, Inc., a pioneering genomics company, unveiled updated mission/vision statement to reflect renewed ambitions in taking on more for a better world, in celebration of its 18th anniversary.

June 14, 2023
·
5 min read
Business

LivaNova to Announce Second-Quarter 2023 Results

LivaNova PLC, a market-leading medical technology and innovation company, will host a conference call to discuss its second-quarter 2023 results on Wednesday, July 26, 2023 at 1 p.m. London time.

June 14, 2023
·
2 min read
Biotech Bay

Cala® Launches The Cala kIQ™ System, Offering Meaningful Tremor Relief for Patients With Essential Tremor and Now Parkinson’s Disease

Cala today announced the commercial launch of its next generation system: the Cala kIQ™ System, the first and only FDA-cleared wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor and Parkinson’s disease.

June 14, 2023
·
4 min read
Business

Agendia Appoints Ronald Andrews and David Schreiber to Board of Directors

Agendia, Inc., a gene expression profiling company advancing personalized early-stage breast cancer care, announced the appointment of industry veterans Ronald Andrews and David Schreiber to the company’s Board of Directors.

June 14, 2023
·
4 min read
Genetown

Stealth BioTherapeutics CEO Reenie McCarthy Highlights Opportunities and Challenges in Ultra-Rare Disease Drug Development at World Orphan Drug Congress USA

Stealth BioTherapeutics Inc. provided key takeaways from a presentation by Reenie McCarthy, the Company’s Chief Executive Officer, at the World Orphan Drug Congress USA, held May 23-25 in Washington, D.C.

June 14, 2023
·
6 min read
Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic

ROCHESTER, Minn., June 14, 2023 /PRNewswire/ -- Vyriad, Inc., announces an expansion of a Phase 1 investigator-initiated trial at Mayo Clinic evaluating the safety and efficacy of Voyager-V1 (VSV-hIFNbeta-NIS) in patients with peripheral T-cell lymphoma (PTCL) following encouraging initial results1.

June 14, 2023
·
2 min read
Biotech Beach

Kura Oncology Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants

Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, announced the pricing of an underwritten public offering of common stock and pre-funded warrants.

June 14, 2023
·
5 min read
BioMidwest

Monopar to Participate in the Maxim Group’s Healthcare Virtual Conference

Monopar Therapeutics Inc. announced that Chandler Robinson, MD, Monopar’s Chief Executive Officer, will participate in a one-on-one fireside chat with Jason McCarthy, PhD, Senior Managing Director of Equity Research, at the Maxim Group’s Healthcare Virtual Conference on Tuesday June 20, 2023 at 1:30pm ET.

June 14, 2023
·
1 min read